Latest Resources
29 May 2006
Bioethanol-Maize / Syngenta
COMMENTS BY THE AFRICAN CENTRE FOR BIOSAFETY AND THE CENTRE FOR FOOD SAFETY (USA) Comments on Syngenta’s Application for Commodity Clearance of Genetically Modified Maize, Event 3272 African Centre for Biosafety & Centre for Food Safety, 29 May 2006 Read here. OVERVIEW Syngenta’s Event 3272 maize represents the very first genetically modified (GM) industrial crop […]
6 May 2006
South Africa, Bioethanol and GMOs: A Heady Mixture
On the 12th of May 2006 Syngenta South Africa (Pty) Ltd, a subsidiary of Swiss chemical giant Syngenta, notified the public of its intention to seek commodity clearance for its GM maize for the use in the production of ethanol. This is the first GM application for commercial approval in the world for a non-feed, […]
1 March 2006
The status of Genetically Modified (GM) pharmaceutical crop research in South Africa
Genetically modified (GM) pharmaceutical crops are crops which have been genetically engineered / modified to produce pharmaceuticals. These pharmaceuticals can be vaccines, anti-bodies or therapeutic proteins. Pharma-crops (as they are known) are a contested and little-known terrain, with remarkable benefits being claimed for them in South Africa. Other voices ask about the contamination of the […]
27 January 2006
Biohazard Map of GM Field Trials in SA
Now that the dust is settling after industry’s aggressive PR hype about the unsubstantiated increase in South Africa’s GM commercial plantings for 2006, we bring to you, based upon empirical data, a short briefing paper on the field trials of GMOs grown in South Africa during 2006, compiled by ACB researcher, Rose Williams. This briefing […]
24 January 2006
Bt-Maize 1507 x 59122 x NK 603 / Dow Agrosciences
SUBMISSION OF OBJECTIONS BY THE AFRICAN CENTRE FOR BIOSAFETY (ACB). OBJECTION TO APPLICATION BY DOW AGROSCIENCES TRIPLE STACKED GM MAIZE, EVENTS, 1507 x NK603 x 59199. Read objection here. OVERVIEW The African Centre for Biosafety (ACB) has to date, lodged objections to the following applications by Dow Agrosciences for commodity import clearance: – GM Maize […]
4 December 2005
Roundup Ready Flex Cotton / Monsanto
SUBMISSION OF OBJECTIONS BY THE AFRICAN CENTRE FOR BIOSAFETY (ACB) OBJECTION TO MONSANTO’S APPLICATION FOR GENERAL RELEASE OF GM COTTON RR FLEX African Centre for Biosafety, Dec 2005 Read here. Summary The application is for a general release permit to allow the commercial sale and growing of a new transformation event MON88913, also known as […]
1 October 2005
Bt-Maize MON89034 and MON89597 / Monsanto
SUBMISSION OF OBJECTIONS BY THE AFRICAN CENTRE FOR BIOSAFETY (ACB) Objections To The Application Made By Monsanto South Africa For A Permit For A Trial Release Of Mon89034 And Mon89597 African Centre for Biosafety, 01 Oct 2005 OVERVIEW DEVELOPER (MONSANTO) APPLICATION: AVAILABLE INFORMATION The dossier supplied by Monsanto is designated Non Confidential Business Information (Non-CBI). […]
11 August 2005
Zambia – GMO Legislation
INTRODUCTION The Draft Labeling Standards are non-binding in the sense that they do not create legally binding obligations and responsibilities. As such, they are also not legally enforceable. The lack of teeth of the standards is not cured by the fact that the Zambian Bureau of Standards, a statutory body, produces the standards. However, the […]
29 June 2005
Sugarcane with altered sugar metabolism & new promotor elements (SARSI) / SARSI
Sugarcane with altered sugar metabolism & new promotor elements (SARSI) / SARSI Objection To The Application By Sasri In Respect Of A Trial With Gm Sugarcane, To The National Department Of Agriculture, South Africa. Read here. SCIENTIFIC ASSESSMENT BACKGROUND Application by SASRI and Available Information An application has been made by the South African Sugarcane […]
4 May 2005
BT-Maize MIR 604 / SYNGENTA
SUBMISSION OF OBJECTIONS BY THE AFRICAN CENTRE FOR BIOSAFETY (ACB) Objection To The Application By Syngenta For Commodity Clearance Of Syngenta Mir604 Maize To The National Department Of Agriculture, South Africa African Centre for Biosafety, 27 May 2005 Read here. OVERVIEW SUMMARY OF ISSUES RAISED IN OBJECTION The discussion below details our concerns against the […]